Marco Ramadani

1.5k citations

24 papers · 1.2k indexed · 1 hit paper · h-index 13

Co-authors: H. G. Beger Frank Gansauge Susanne Gansauge Alexandra Schmid‐Kotsas Max G. Bachem Shaoxia Zhou Guido Adler Andreas K. Buck
Topics: Pancreatic and Hepatic Oncology Research (6 papers)Pancreatitis Pathology and Treatment (5 papers)Cell death mechanisms and regulation (4 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Gastroenterology Annals of Surgery Clinical Cancer Research
Partner nations: Germany United States China

In The Last Decade

Marco Ramadani

23 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells

2005 515 citations Max G. Bachem, Marco Ramadani et al. Gastroenterology profile →

Peers

Countries citing papers authored by Marco Ramadani

Since Specialization

Citations

This map shows the geographic impact of Marco Ramadani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Ramadani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Ramadani more than expected).

Fields of papers citing papers by Marco Ramadani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Ramadani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Ramadani. The network helps show where Marco Ramadani may publish in the future.

Co-authorship network of co-authors of Marco Ramadani

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Ramadani. A scholar is included among the top collaborators of Marco Ramadani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Ramadani. Marco Ramadani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The tobacco carcinogen NNK is stereoselectively reduced by human pancreatic microsomes and cytosols 2008 ·Langenbeck s Archives of Surgery ·Neil Trushin,Gerhard Leder,Karam El‐Bayoumy,Dietrich Hoffmann,H. G. Beger,Doris Henne‐Bruns,Marco Ramadani,Bogdan Prokopczyk	12
2	Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay 2007 ·Langenbeck s Archives of Surgery ·(unknown),(unknown),H. Gerngroß,Roland Schmidt,(unknown),Marco Ramadani,Susanne Gansauge	2
3	Systemic immune dysfunction in pancreatic cancer patients 2007 ·Langenbeck s Archives of Surgery ·Bertram Poch,(unknown),Marco Ramadani,Susanne Gansauge,Hans G. Beger,Frank Gansauge	41
4	Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cellsbreakdown → 2005 ·Gastroenterology ·Max G. Bachem,(unknown),Marco Ramadani,Marco Siech,H. G. Beger,Andreas K. Buck,Shaoxia Zhou,Alexandra Schmid‐Kotsas,Guido Adler	515
5	4-Hydroxy-1-(3-pyridyl)-1-butanone, an Indicator for 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone–Induced DNA Damage, Is Not Detected in Human Pancreatic Tissue 2005 ·Cancer Epidemiology Biomarkers & Prevention ·Bogdan Prokopczyk,Gerhard Leder,Neil Trushin,A. J. Cunningham,Shobha A. Akerkar,Brian Pittman,Marco Ramadani,(unknown),H. G. Beger,Doris Henne‐Bruns,Karam El‐Bayoumy	9
6	Comparative Analysis of Extracellular Matrix Proteins in Chronic Pancreatitis: Differences Between Pancreatic Head and Tail 2004 ·Pancreas ·Bernd M. Muehling,(unknown),Marco Ramadani,Elizabeth Moreira dos Santos Schmidt,Frank Gansauge,H.G. Beger	3
7	Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma 2004 ·Clinical Cancer Research ·Carmela Beger,Marco Ramadani,S. S. Meyer,Gerd Leder,Martin Krüger,Karl Welte,Frank Gansauge,Hans G. Beger	28
8	NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer 2002 ·Langenbeck s Archives of Surgery ·Frank Gansauge,Marco Ramadani,Jochen Preßmar,Susanne Gansauge,Bernd M. Muehling,(unknown),(unknown),Gerd Leder,Hans G. Beger	33
9	Cyclooxygenase-2 is Overexpressed in Chronic Pancreatitis 2002 ·Pancreas ·Wolfgang Schlosser,(unknown),Marco Ramadani,Frank Gansauge,Susanne Gansauge,H.G. Beger	58
10	Epidermal Growth Factor Induces Cyclin D1 in Human Pancreatic Carcinoma: Evidence for a Cyclin D1–Dependent Cell Cycle Progression 2001 ·Pancreas ·Bertram Poch,Frank Gansauge,Andreas Schwarz,Thomas Seufferlein,Thomas Schnelldorfer,Marco Ramadani,H. G. Beger,Susanne Gansauge	39
11	Reduced membranous and ectopic cytoplasmic expression of ? -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer 2001 ·International Journal of Cancer ·(unknown),Marco Ramadani,Susanne Gansauge,Frank Gansauge,Gerd Leder,(unknown)	70
12	Distributional and Functional Alterations of Immunocompetent Peripheral Blood Lymphocytes in Patients with Chronic Pancreatitis 2001 ·Annals of Surgery ·Frank Gansauge,Susanne Gansauge,(unknown),Wolfgang Schlosser,Marco Ramadani,Peter Kern,H. G. Beger	19
13	Inhibition of caspase‐1 induces cell death in pancreatic carcinoma cells and potentially modulates expression levels of bcl‐2 family proteins 2001 ·FEBS Letters ·(unknown),Frank Gansauge,Marco Ramadani,H. G. Beger,Susanne Gansauge	14
14	Overexpression of Caspase-1 (Interleukin-1β Converting Enzyme) in Chronic Pancreatitis and Its Participation in Apoptosis and Proliferation 2001 ·Pancreas ·Marco Ramadani,Yinmo Yang,Frank Gansauge,Susanne Gansauge,Hans G. Beger	12
15	Overexpression of caspase-1 in pancreatic disorders: implications for a function besides apoptosis 2001 ·Journal of Gastrointestinal Surgery ·Marco Ramadani,Frank Gansauge,(unknown),Yinmo Yang,(unknown),Susanne Gansauge	7
16	Reduced membranous and ectopic cytoplasmic expression of β ‐catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer 2001 ·International Journal of Cancer ·(unknown),Marco Ramadani,Susanne Gansauge,Frank Gansauge,Gerd Leder,H. G. Beger	0
17	A possible mechanism for metastasation and invasion of cancer cells by mimicking macrophage invasiveness 2000 ·Gastroenterology ·(unknown),Marco Ramadani,Hans G. Beger,Frank Gansauge	1
18	CD44v6 cell surface expression is a common feature of macrophages and macrophage‐like cells – implication for a natural macrophage extravasation mechanism mimicked by tumor cells 2000 ·FEBS Letters ·Heidi Braumüller,Susanne Gansauge,Marco Ramadani,Frank Gansauge	11
19	Inhibition of epidermal growth factor-induced interleukin-1beta-converting enzyme expression reduces proliferation in the pancreatic carcinoma cell line AsPC-1. 1999 ·PubMed ·(unknown),Frank Gansauge,Thomas Schnelldorfer,Marco Ramadani,Anja Schwarz,H. G. Beger,Susanne Gansauge	3
20	Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreas. 1998 ·PubMed ·Susanne Gansauge,Frank Gansauge,Yinmo Yang,Jörg Müller,Thomas Seufferlein,Marco Ramadani,H. G. Beger	21

About Marco Ramadani

Marco Ramadani is a scholar working on Oncology, Cancer Research and Immunology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Pancreatitis Pathology and Treatment (5 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Oncology (795 citations), Cancer Research (201 citations) and Immunology (198 citations). Marco Ramadani has collaborated with scholars based in Germany, United States and China. Frequent co-authors include H. G. Beger, Frank Gansauge, Susanne Gansauge, Alexandra Schmid‐Kotsas, Max G. Bachem, Shaoxia Zhou, Guido Adler, Andreas K. Buck, Marco Siech and H Stobbe. Their work appears in journals such as Gastroenterology, Annals of Surgery and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact